https://doi.org/10.1016/j.vaccine.2019.05.030 0264-410X/ 2019 Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). ⇑ Corresponding author. E-mail address: secretariat@brightoncollaboration.org (N. Chescheir). 1 Brighton Collaboration home page: http://www.brightoncollaboration.org. Alisa Kachikis , Linda O. Eckert , Christie Walker , Azucena Bardají , Frederick Varricchio , Heather S. Lipkind , Khady Diouf , Wan-Ting Huang , Ronald Mataya , Mustapha Bittaye , Clare Cutland , Nansi S. Boghossian , Tamala Mallett Moore , Rebecca McCall , Jay King , Shuchita Mundle , Flor M. Munoz , Caroline Rouse , Michael Gravett , Lakshmi Katikaneni , Kevin Ault , Nicola P. Klein , Drucilla J. Roberts , Sonali Kochhar , Nancy Chescheir p,⇑, The Brighton Collaboration Chorioamnionitis Working Group 1
No takes yet. Share an insight, caveat, or question.
Kachikis et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: